Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Antoch

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
European Journal of Radiology|April 1, 2019
Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patientsT Ullrich, C Arsov, M Quentin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2003
FDG-PET/CT in re-staging of patients with lymphomaL S Freudenberg, G Antoch, P Schütt, et al.
Scientific Reports|April 26, 2022
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostateM Boschheidgen, L Schimmöller, S Doerfler, et al.
European Radiology|February 28, 2016
Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?L Schimmöller, M Quentin, D Blondin, et al.
Magnetic Resonance Imaging|February 12, 2025
Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admissionM Boschheidgen, L Drewes, B Valentin, et al.
European Journal of Radiology|December 24, 2021
Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancerB Valentin, C Arsov, T Ullrich, et al.
Der Radiologe|October 29, 2011
[Case-based interactive PACS learning: introduction of a new concept for radiological education of students]A Scherer, P Kröpil, P Heusch, et al.
European Radiology|November 8, 2021
MRI grading for the prediction of prostate cancer aggressivenessM Boschheidgen, L Schimmöller, C Arsov, et al.
Data in Brief|November 25, 2022
Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsyM Klingebiel, C Arsov, T Ullrich, et al.
European Journal of Radiology|February 16, 2021
Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsyM Klingebiel, C Arsov, T Ullrich, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
European Journal of Radiology|April 1, 2019
Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patientsT Ullrich, C Arsov, M Quentin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2003
FDG-PET/CT in re-staging of patients with lymphomaL S Freudenberg, G Antoch, P Schütt, et al.
Scientific Reports|April 26, 2022
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostateM Boschheidgen, L Schimmöller, S Doerfler, et al.
European Radiology|February 28, 2016
Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?L Schimmöller, M Quentin, D Blondin, et al.
Magnetic Resonance Imaging|February 12, 2025
Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admissionM Boschheidgen, L Drewes, B Valentin, et al.
European Journal of Radiology|December 24, 2021
Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancerB Valentin, C Arsov, T Ullrich, et al.
Der Radiologe|October 29, 2011
[Case-based interactive PACS learning: introduction of a new concept for radiological education of students]A Scherer, P Kröpil, P Heusch, et al.
European Radiology|November 8, 2021
MRI grading for the prediction of prostate cancer aggressivenessM Boschheidgen, L Schimmöller, C Arsov, et al.
Data in Brief|November 25, 2022
Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsyM Klingebiel, C Arsov, T Ullrich, et al.
European Journal of Radiology|February 16, 2021
Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsyM Klingebiel, C Arsov, T Ullrich, et al.
Pageof 12